http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6058760

Outgoing Links

Predicate Object
contentType Journal Article
issn 2234-943X
pageRange 886-
publicationName Frontiers in Oncology
startingPage 886
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8e94131eebe43165d2342314744a4bae
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cabe87d97f122d4519c6b14d45d1248c
bibliographicCitation Lu J, Shi Q, Zhang L, Wu J, Lou Y, Qian J, Zhang B, Wang S, Wang H, Zhao X, Han B. Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line. Front Oncol. 2019;9():886. PMID: 31572680; PMCID: PMC6749025.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49a5ca351ba50a234be869c5c33297fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3330e3c88e8a904fa1b109dc7178a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f414fa6845f7d062ddf26dc0d89d635
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0731eea4be18b9d8eae72a589dc751b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91754fa1eca6ea7171700c73f920c499
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2eac4bd2e1d470bd9e195a2a48b1b996
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53cd8ce6f27a80af59906b1940075821
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7343-9706
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc31a1de01acfa167cd0f453c296bd97
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_414da1c5c9fd4bd4355fa3cf504fdfc9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e45870ccb04bb7d330ded8a894817fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e67e125606960f4f0d719d6cd06ff962
date 2019-09-11^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/31572680
https://pubmed.ncbi.nlm.nih.gov/PMC6749025
https://doi.org/10.3389/fonc.2019.00886
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509
https://portal.issn.org/resource/ISSN/2234-943X
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f4833757042e42d59f06364389989d63
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25017411
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f024f06fc55f421fc0076a7abd062e69
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Showing number of triples: 1 to 37 of 37.